PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States ,Germany ,Australia ,Japan ,Netherlands ,United Kingdom ,Ireland ,Indonesia ,South Korea ,Washington ,Seattle ,Republic Of Korea ,Irish ,Korea ,Mel Spigelman ,Ruxandra Draghia Akli ,Emilio Emini ,Mark Suzman ,Bill Gates ,Delamanid Deltyba ,Werner Lanthaler ,Australia Department Of Foreign Affairs ,Linkedin ,National Institute Of Allergy ,Netherlands Ministry Of Foreign Affairs ,Melinda Gates Foundation ,Global Health Innovative Technology Fund ,Janssen Research Development ,Cystic Fibrosis Foundation ,Janssen Pharmaceutical Companies Of Johnson ,Indonesia Health Fund ,United States Agency For International Development ,Pfizer ,Tb Alliance ,Global Disease Eradication Fund Korea ,European Union ,Melinda Gates Medical Research Institute ,Otsuka Pharmaceutical Co Ltd ,Drug Administration ,World Health Organization ,Germany Federal Ministry Of Education ,Development Office United Kingdom ,Otsuka Pharmaceutical Co ,Korea International Cooperation Agency ,Companies Of Johnson ,Republic Of Korea Ministry Foreign Affairs ,Global Head Of Public Health ,Research Council United Kingdom ,Johnson ,Accelerate New Treatments ,Janssen Pharmaceutica ,Janssen Pharmaceutical Companies ,Medicines Patent Pool ,Melinda Gates Medical Research ,Melinda Gates ,Otsuka Pharmaceutical ,Global Head ,Janssen Research ,European Regimen Accelerator ,Pharmaceutical Companies ,Infectious Diseases ,Foreign Affairs ,Development Office ,Federal Ministry ,Global Disease Eradication Fund ,Irish Aid ,Medical Research Council ,National Institute ,Netherlands Ministry ,United States Agency ,Melinda French Gates ,Essential Medicines ,Novel Carbostyril Derivative ,Potent Antituberculosis Activity ,Antimicrob Agents ,Technology ,Health ,Pr Newswire ,Philanthropy ,United Nations ,Clinical Trials ,Europe ,Tuberculosis ,Business ,